Renal involvement in bone marrow transplantation

Nephrology

Volumn 10, Issue 5, 2005, Pages 530-536

  Otani, Masako ^a   Shimojo, Hisashi ^a   Shiozawa, Satoshi ^b   Shigematsu, Hidekazu ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Saku General Hospital   (Japan)

Author keywords

Bone marrow transplantation; Cyclosporine A; Graft versus host disease; Haemolytic uraemic syndrome; Radiation nephropathy

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN A;

BONE MARROW TRANSPLANTATION; CELL DAMAGE; ENDOTHELIUM CELL; GLOMERULONEPHRITIS; GRAFT VERSUS HOST REACTION; HEMOLYTIC UREMIC SYNDROME; HISTOLOGY; HUMAN; KIDNEY DISEASE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION; REVIEW;

ANIMALS; BONE MARROW TRANSPLANTATION; GLOMERULONEPHRITIS; GRAFT VS HOST DISEASE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; LEUKEMIA;

EID: 28444451121     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00478.x     Document Type: Review

References (65)

1. Jennette JC, Olson JL, Schwanz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney. Philadelphia, PA: Lippincott-Raven, 1998.
2. Cohen EP, Lawton CA, Moulder JE. Bone marrow transplant nephropathy: Radiation nephritis revisited. Nephron 1995; 70: 217-22.
3. Bergstein J, Andreoli SP, Provisor AJ, Yum M. Radiation nephritis following total-body irradiation and cyclophophamide in preparation for bone marrow transplantation. Transplantation 1986; 41: 63-6.
4. Gomez-Garcia P, Herrera-Arriti C, Torres-Gomez A et al. Renal involvement in chronic graft-versus-host disease: A report of two cases. Bone Marrow Transplant. 1988; 3: 357-62.
5. Hiesse C, Goldschmidt E, Santelli G, Charpentier B, Machover D, Feise D. Membranous nephropathy in a bone marrow transplant recipient. Am. J. Kidney Dis. 1988; 11: 188-91.
6. Müller GA, Müller CA, Markovic-Lipkowski J et al. Membranous nephropathy after bone marrow transplantation in cyclosporine treatment. Nephron 1989; 51: 555-6.
7. Barbara JA, Thomas AC, Smith PS, Gillis D, Ho JOK, Woodroffe AJ. Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient. Clin. Nephrol. 1992; 37: 115-18.
8. Walker JV, Morich D, Anasetti C. Minimal change nephrotic syndrome after cyclosporine withdrawal in a marrow transplant recipient. Am. J. Kidney Dis. 1995; 26: 532-4.
9. Sato N, Nishi K, Yagisawa K et al. Nephrotic syndrome in a bone marrow transplant recipient with chronic graft-versus-host disease. Bone Marrow Transplant. 1995; 16: 303-5.
10. Yabana M, Takagi N, Kihara M et al. A case of nephrotic syndrome after bone marrow transplantation, J. Nephrol. 1997; 39: 414-20.
11. Yorioka N, Taniguchi Y, Shimote K et al. Membranous nephropathy with chronic graft-versus-host disease in a bone marrow transplant recipient. Nephron 1998; 80: 371-2.
12. Oliveria IS, Bahia D, Franco MZ, Balda C, Stella S, Kerbauy J. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant. 1999; 23: 99-101.
13. Nergizoglu G, Keven K, Ates K et al. Chronic graft-versus-host disease complicated by membranous glomerulonephritis. Nephrol. Dial. Transplant. 1999; 14: 2461-3.
14. Ohsawa I, Ohi H, Fujita T et al. Glomerular and extraglomerular immune complex deposits in a bone marrow transplant recipient. Am. J. Kidney Dis. 2000; 36: 1-5.
15. Lin J, Markowitz GS, Nicolaides M et al. Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation: Report of 2 cases and review of the literature. Am. J. Nephrol. 2001; 21: 351-6.
16. Rossi L, Cardarelli F, Vampa ML, Buzio C, Olivetti G. Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma. Nephron 2001; 88: 260-63.
17. Suehiro T, Matsutani K, Yokoyama M et al. Diffuse proliferative glomerulonephritis after bone marrow transplantation. Clin. Nephrol. 2002; 58: 231-7.
18. Kimura S, Horie A, Hiki Y et al. Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma. Blood 2003; 101: 4219-21.
19. Gliechmann H, Gleichmann E, Andreschwartz J, Schartz RS. Chronic allogeneic disease. III. Genetic requirements for the induction of glomerulonephritis. J. Exp. Med. 1972; 135: 516-32.
20. Allen RD, Dobkins JA, Harper JM, Slayback DL. Genetics of graft-versus-host disease. I. A locus on chromosome 1 influences development of acute graft-versus-host disease in a major histo-compatibility complex mismatched murine model. Immunology 1999; 96: 254-61.
21. Pals ST, Gleichmann H, Gleichmann E. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. Fl mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells, j. Exp. Med. 1984; 159: 508-23.
22. Lewis RM, Armstrong MYK, Andreschwartz J, Muftoulu A, Beldotti L, Schwarz RS. Chronic allogeneic disease. I. Development of glomerulonephritis. J. Exp. Med. 1968; 128: 653-79.
23. Bruijn JA, Van Elven EH, Hogendoorn PCW, Corver WE, Hoedemaeker PJ, Fleuren GJ. Animal model of human disease: Murine chronic graft-versus-host disease as model for lupus nephritis. Am. J. Pathol. 1988; 130: 639-41.
24. Bruijn JA, Bergijk EC, De Heer E, Fleuren GJ, Hoenmaeker PJ. Induction and progression of experimental lupus nephritis: exportation of a pathogenetic pathway. Kidney Int. 1992; 41: 5-13.
25. Dobashi K, Ono S, Murakami S, Takahama Y, Katoh Y, Hamaoka T. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease, J. Immunol. 1987; 138: 781-7.
26. Doutrelepont JM, Moser M, Leo O, Abramowicz D, Vanderhaegen ML. Hyper IgE in stimulatory graft-versus-host disease: Role of interleukin-4. Clin. Exp. Immunol. 1991; 83: 133-6.
27. Goldman M, Druet P, Gleichmann E. TH2 cells in systemic autoimmunity: Insights from allogeneic disease and chemically induced autoimmunity. Immunol. Today 1991; 12: 223-7.
28. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N. Engl. J. Med. 1982; 307: 652-9.
29. Relink AG, Radaszkiewicz T, Melchers F. The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host diseased mice. J. Exp. Med. 1987; 165: 1675-87.
30. Rolink AG, Thalmann P, Berger C, Radaszkiewicz T, Melchers F. Autoreactive B-cell repertoire in mice with chronic graft-versus-host disease. Mol. Immunol. 1988; 25: 1217-22.
31. Aoki I, Aoki A, Otani M et al. A correlation between IgG class antibody production and glomerulonephritis in the murine chronic graft-versus-host reaction. Clin. Immunol. Immunopathol. 1992; 63: 34-8.
32. Bruijn JA, Hogendoorn PCW, Corver WE, Van der Broek LJCM, Hoenmaeker PJ, Fleuren GJ. Pathogenesis of experimental lupus nephritis: A role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin. Exp. Immunol. 1990; 79: 115-28.
33. Bruijn JA, Van Leer EHG, Baelde JJ, Corver WE, Hogendoorn PCW, Fleuren GJ. Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis. Lab. Invest. 1990; 63: 350-59.
34. Aoki A, Ishigatsubo Y, Hagiwara E et al. Polyclonal B cell activation and antigen-specific stimulation in mice with chronic graft-versus-host reaction. Clin. Immunol. Immunopathoi. 1993; 66: 254-9.
35. Portanova JP, Claman HN, Kotsin BL. Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histone and DNA. J. Immunol. 1985; 135: 3850-56.
36. Portanova JP, Arndt RE, Kotsin BL. Selective production of autoantibodies in graft-vs-host-induced and spontaneous murine lupus: Predominant reactivity with histone regions accessible in chromatin. J. Immunol. 1988; 140: 755-60.
37. Rolink AG, Radaszkiewicz T, Melchers F. Monoclonal autoanti-bodies specific for kidney proximal tubular brush border from mice with experimentally induced chronic graft-versus-host disease. Scand. J. Immunol. 1988; 28: 29-41.
38. Bruijn JA, Hoendoorn PCW, Corver WE, Elven EH, Van Hoendemaeker PJ, Fleuren GJ. Renal pathology and characterization of glomerular sclerosis in murine chronic graft-versus-host disease. Nephrol. Dial. Transplant. 1987; 2: 422.
39. Sutmuller M, Ekstijn GL, Ouellette S, De Heer E, Bruijn JA. Non-MHC genes determine the development of lupus nephritis in H-2 identical mouse strains. Clin. Exp. Immunol. 1996; 106: 265-72.
40. Via CS, Sharrow SO, Shearer GM. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-versus-host disease, J. Immunol. 1987; 139: 1840-49.
41. Otani M, Aoki I, Miyagi Y et al. Glomerulonephritis induced by murine chronic graft-versus-host reaction. Acta Pathol. Jpn. 1992; 42: 325-32.
42. Otani M, Aoki I, Aoki A, Misugi K. Comparative study of the glomerular involvement in two different strains of mice induced by murine graft-versus-host reaction. Med. Electron Microsc. 1995; 28: 6-16.
43. Traynor A, Kuzel T, Samuelson E, Kanwar Y. Minimal-change glomererulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma. Nephron 1994; 67: 94-100.
44. Borel JF, Feurer C, Gubler HU, Stahelin H. Biological effects of cyclosporine A: A new antilymphocytic agent. Ag. Actions. 1976; 6: 468-75.
45. Powles RL, Clink HM, Spence D et al. Cyclosporine A to prevent graft versus host disease in man after allogeneic bone-marrow transplantation. Lancet 1980; 1: 327-9.
46. Charak BS, Agah R, Mazumder A. Synergism of interleukin-2 and cyclosporine A in induction of a graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation. Blood 1992; 80: 179-84.
47. Priud'homme GJ, Parfroy NA, Vanier LE. Cyclosporine-induced autoimmunity and immune hyperreactivity. Autoimmunity 1991; 9: 345-56.
48. Antignac C, Gubler MC, Leverger G, Broyer M, Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int. 1989; 35: 1336-44.
49. Arends MJ, Harrison DJ. Novel histopathologic findings in a surviving case of hemolytic uremic syndrome after bone marrow transplantation. Hum. Pathol. 1989; 20: 89-91.
50. Loomis LJ, Aronson AJ, Rudinsky R, Spargo BH. Hemolytic uremic syndrome following bone marrow transplantation: A case report and review of the literature. Am. J. Kidney Dis. 1989; 14: 324-8.
51. Rabinowe SN, Soiffer RJ, Tarbell NJ et al. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologie malignancies. Blood 1991; 77: 1837-14.
52. Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int. 1994; 46: 1443-58.
53. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant. 1994; 14: 495-504.
54. Gharpure VS, Devine SM, Holland HK, Geller RB, O'Toole K, Wingard JR. Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation. Bone Marrow Transplant. 1995; 16: 715-6.
55. Srivastava A, Gottlieb D, Bradstock KF. Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995; 15: 863-7.
56. Cohen EP, Bull HA, Seddon A et al. Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation. Eur. J. Haematol. 1989; 43: 207-14.
57. Shulman H, Striker G, Deag HJ, Kennedy M, Storb R, Thomas ED. Nephrotoxicity of cyclosporine A after allogeneic bone marrow transplantation: Glomerular thromboses and tubular injury. N. Engl. J. Med. 1981; 305: 1392-5.
58. Marshall RJ, Sweny P. Haemolytic-uremic syndrome in recipients of bone marrow transplants not treated with cyclosporine A. Histopathology 1986; 10: 953-62.
59. Ousler DP, Holley KE, Wagoner RD. Hemolytic uremic syndrome after bone marrow transplantation without total body irradiation. Am. J. Nephrol. 1993; 13: 167-70.
60. Luxton RW. Radiation nephritis: A long term study of fifty-four patients. Lancet 1961; 2: 1221-4.
61. Aviolo LV, Lazor MZ, Cotlove E et al. Early effects of radiation on renal function in man. Am. J. Med. 1963; 34: 329.
62. Krochak RJ, Baker DG. Radiation nephritis: Clinical manifestations and pathophysiologic mechanisms. Urology 1986; 27: 389-93.
63. Vigneri P, Arger P, Pollack H, Kligerman MM. Localization and protection of kidneys in radiation treatment planning using computed tomography. Int. J. Radiat. Oncol. Biol. Phys. 1985; 11: 1209-13.
64. Chappell ME, Keeling DM, Prentice HG, Sweny P. Haemolytic uraemic syndrome after bone marrow transplantation: An adverse effect of total body irradiation? Bone Marrow Transplant. 1988; 3: 339-47.
65. Down JD, Berman AJ, Warhol M, Yeap B, Mauch P. Late complications following total-body irradiation and bone marrow rescue in mice: Predominance of glomerular nephropathy and hemolytic anemia. Int. J. Radiat. Biol. 1990; 57: 551-65.